Off-Label Use
-
Subject Areas on Research
- A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.
- A hemorrhage of off-label use.
- ALSUntangled 56: "ten red flags"-things to be wary of in alternative or off-label products.
- Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent.
- Apremilast for the off-label treatment of lichenoid and interface dermatoses.
- Availability of experimental therapy outside oncology randomized clinical trials in the United States.
- Conflict of interest disclosure in off-label oncology clinical trials.
- Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.
- Diuretic exposure in premature infants from 1997 to 2011.
- Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.
- Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
- Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.
- Impact of Diuretic Therapy in the Treatment of Bronchopulmonary Dysplasia and Acute Kidney Injury in the Neonatal Population.
- Improving evidence developed from population-level experience with targeted agents.
- Is the HCV pipeline heading in the right direction?
- Lisdexamfetamine Dimesylate (Vyvanse) for the Treatment of Neurogenic Anejaculation.
- Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.
- Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
- Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.
- Off-Label Use of the WEB Device.
- Off-label closure during CLOSURE study.
- Off-label uses of the Pipeline embolization device: a review of the literature.
- Pharmacologic studies in vulnerable populations: Using the pediatric experience.
- Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program.
- Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.
- Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
- Safety of octreotide in hospitalized infants.
- Safety of recombinant activated factor VII in randomized clinical trials.
- Surfactant Administration in Preterm Infants: Drug Development Opportunities.
- The Judicious Use of Recombinant Factor VIIa.
- Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry.
- Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.
- What should work, may not.